Sentences with phrase «surgical aortic valve»

Of 795 patients randomly assigned to valve replacement by catheter or surgery, 747 patients underwent one of the procedures: 390 in the transcatheter aortic valve replacement (TAVR) arm and 357 in the surgical aortic valve replacement arm.

Degenerative aortic stenosis is a progressive disease with a poor prognosis in the absence of surgical aortic valve replacement.

«The first year results from the CoreValve US Pivotal Trial support the safety and efficacy of this therapy in patients unsuitable for surgical aortic valve replacement,» said lead investigator Steven Yakubov, MD..

Roughly 1 in 5 patients undergoing surgical aortic valve replacement in the U.S. are estimated to be intermediate - risk; so together, intermediate - and high - risk patients comprise the top quartile of all patients needing an aortic valve replacement.

Not exact matches

The company develops and markets a broad range of medical devices, such as advanced surgical technology, insulin pumps, transcatheter aortic heart valves, and much more.

TAVR, also known as transcatheter aortic valve implantation (TAVI), is a minimally invasive surgical procedure that repairs the valve without removing the old, damaged valve.

TAVR was first approved by the U.S. Food and Drug Administration (FDA) in 2011 to treat patients with severe aortic valve stenosis — a problem that occurs when the valve in the heart's main artery doesn't open fully and forces the heart to work harder to pump blood — for whom standard surgical valve replacement is too risky.

With this latest approval, the Orlando Health Heart Institute now also offers the CoreValve System to patients who are considered at high risk for a surgical heart procedure, serving a broader range of U.S. patients than any other transcatheter aortic valve.

The study is the first systematic scientific study using four - dimensional CT angiography to assess valve performance of TAVR and surgical tissue valves in patients with aortic stenosis.

Transcatheter aortic valve replacement with a self - expanding valve prosthesis for the first time has demonstrated significantly lower death rates at one year compared with conventional surgical valve replacement in high - risk patients with severe aortic stenosis, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session.

For patients at extreme risk for surgical complications, transcatheter aortic valve technologies offer a less invasive option of therapy for aortic stenosis.

Their analysis involved approximately 300,000 patients who had undergone 11 major surgical procedures, including coronary artery bypass grafting, aortic valve replacement and appendectomy.

The collaborative team is currently developing a new method to use the body's own stem cells to create aortic valves for cardiothoracic surgical implantation.